课题基金 / 基金详情

Ulcerative colitis-associated cancer and its prevention

Ulcerative colitis-associated cancer and its prevention
溃疡性结肠炎相关癌症及其预防
批准号:
7430444
负责人:
Guang-Yu Yang
金额:
$21.68万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2010-05-31

项目摘要

项目成果

Guang-Yu Yang的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of this project is to provide a mechanistic basis for the prevention of Ulcerative colitis (UC)-associated carcinogenesis (UC-Ca). Our unique UC-Ca mouse model will be used to test the hypothesis that leukocyte-NADPH oxidase and endothelial nitric oxide synthase (eNOS) play central roles in UC-Ca by driving nitro-oxidative stress-caused genetic damage and angiogenesis, and by causing cell hyperproliferation via the overproduction of prostaglandin E2 (PGE2) and Leukotriene B4 (LTB4), with the following specific aims: 1. To study the role of leukocyte-generated oxidative stress and associated DNA damage in UC-Ca by using gp91phox (leukocyte NADPH oxidase) and Ogg1 (8-hydroxydeoxyguanine DNA glycosylase) deficient mice. We will test the hypothesis that gp91phox is vital for causing oxidative DNA damage and UC-Ca, and that Ogg1 protects from UC-Ca, using gene knockout mice in the UC-Ca model. 2. To test the hypothesis that eNOS plays a key role in UC-Ca by driving nitro-oxidative stress-caused DNA damage and by promoting angiogenesis, iNOS deficient mice exhibited no difference in susceptibility to UC-Ca or nitrotyrosine formation in our model, but eNOS was expressed in active inflammatory cells. The roles of eNOS or both eNOS/iNOS in UC-Ca will be studied using an eNOS (-/-)mice and the non-selective NOS inhibitor aminoguanidine. 3. To test the hypothesis that inflammation-induced LTB4 and PGE2 overproduction contributes to UCCa by studying the effect of the combination of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5- LOX) inhibitors. COX-2 inhibition exacerbates UC, possibly via the shunting of arachidonic acid substrate to the LTB4 pathway and increasing inflammatory injury. The combination of 5-LOX- and COX-2-specific inhibitors may overcome this problem in the treatment of UC patients. This concept will be tested in our UC-Ca model. 4. To determine the effectiveness of water-soluble and lipid-soluble antioxidants and their combination as a chemopreventive approach against UC-Ca in wild type and Ogg1(-/-) mice. The combination of vitamin E and N-acetylcysteine (NAC) may exert synergistic or additive effects against nitro-oxidative stress, inflammation, and UC-Ca. This concept will be investigated using our UC-Ca model as well as using Ogg1 knockout mice.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/molecules26010031
发表时间: 2020-12-23
期刊: Molecules (Basel, Switzerland)
影响因子: --
作者: [Weinberg SE, Sun LY, Yang AL, Liao J, Yang GY]
通讯作者: Yang GY
DOI: 10.1016/j.humpath.2020.08.002
发表时间: 2020-11
期刊: HUMAN PATHOLOGY
影响因子: 3.3
作者: [Escobar, David, Jones, Ryan, Gao, Juehua, Sun, Leyu, Liao, Jie, Yang, Guang-Yu]
通讯作者: Yang, Guang-Yu
DOI: 10.1038/modpathol.2011.191
发表时间: 2012-05
期刊: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
影响因子: --
作者: []
通讯作者:
DOI: 10.1002/mc.20427
发表时间: 2008-08
期刊: MOLECULAR CARCINOGENESIS
影响因子: 4.6
作者: [Liao, Jie, Seril, Darren N., Lu, Gary G., Zhang, Meng, Toyokuni, Shinya, Yang, Allison L., Yang, Guang-Yu]
通讯作者: Yang, Guang-Yu
Omega-3 derived epoxy fatty acids and sEH in pancreatitis-induced carcinogenesis
Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH
Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH
Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH